ARTICLE | Finance
Fast inflections
Why Longitude Capital joined Cydan's investor syndicate
October 20, 2017 6:45 PM UTC
Longitude Capital joined Cydan Development Inc.’s syndicate with the expectation that spinouts from the rare disease accelerator can deliver returns within three to five years.
The company sources rare disease assets from academia, not-for-profits and industry and funds preclinical and sometimes early clinical development, with the goal of spinning out the most viable programs. ...